Ultiva

Ultiva (marketed by Abbott as Ultiva®) is a potent ultra short-acting synthetic opioid analgesic drug. It is given to patients during surgery to relieve pain and as an adjunct to an anaesthetic. Ultiva is a specific ¼-opioid receptor agonist. Hence, it causes a reduction in sympathetic nervous system tone, respiratory depression and analgesia.

Ultiva - Pharmacology:

Ultiva is a µ-opioid agonist with rapid onset and peak effect, and short duration of action. The µ-opioid activity of remifentanil is antagonized by opioid antagonists such as naloxone.

Ultiva mini report

Ultiva NDA
NDA - A product marketed under an approved New Drug Application
Ultiva INTRAVENOUS
INTRAVENOUS
Ultiva INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Ultiva HUMAN PRESCRIPTION DRUG
HUMAN PRESCRIPTION DRUG
Ultiva global name
Remifentanil Hydrochloride
Start - Stop data
START DATA:
1996-Nov-06
Start - Stop data
STOP DATA
not occurred

Ultiva Interactions

In animals the duration of muscle paralysis from succinylcholine is not prolonged by remifentanil.

Ultiva clearance is not altered by concomitant administration of thiopental, isoflurane, propofol, or temazepam during anesthesia. In vitro studies with atracurium, mivacurium, esmolol, echothiophate, neostigmine, physostigmine, and midazolam revealed no inhibition of remifentanil hydrolysis in whole human blood by these drugs.

Ultiva Contraindications

Due to the presence of glycine in the formulation, ULTIVA is contraindicated for epidural or intrathecal administration. ULTIVA is also contraindicated in patients with known hypersensitivity to fentanyl analogs.

Generic name, Overdose, Half Life Ultiva, Food Interactions, Chemical, etc..

Ultiva see also FDA report


Chemical structure:
O N O O N O O H H H H H H H H H H H H H H H H H H H H H H H H H H H H C20H28N2O5 2D chemical structure C20H28N2O5 SVG | 2D structure Enalapril | Remifentanil | chemical names, chemical properties, classification C20H28N2O5